Lv0
0 积分 2026-01-31 加入
Dupilumab-associated head and neck dermatitis resolves temporarily with itraconazole therapy and rapidly with transition to upadacitinib, with Malassezia-specific immunoglobulin E levels mirroring clinical response
24天前
已完结
Atopic Dermatitis: A Guide to Transitioning to Janus Kinase Inhibitors
24天前
已完结
How are eczema ‘flares’ defined? A systematic review and recommendation for future studies
27天前
已完结
Bridging the gap: combining treat-to-target and difficult-to-treat strategies in the management of rheumatoid arthritis
1个月前
已完结
Treat-to-target in rheumatoid arthritis — are we there yet?
1个月前
已完结
Toward a Multidimensional Framework for Defining Remission in Atopic Dermatitis
1个月前
已完结
Increasing dosing intervals for biologics in atopic dermatitis‐why, who, when and how?
1个月前
已完结
569 - Impact of therapeutic inertia on patient-reported outcomes in moderate-to-severe atopic dermatitis: a 12-month longitudinal study from the TARGET-DERM AD registry
1个月前
已完结
Artificial intelligence chatbots for atopic dermatitis: Accuracy, readability, and concordance with American Academy of Dermatology guidelines
2个月前
已关闭
Long-Term Real-World Evaluation of Abrocitinib in Moderate-to-Severe Atopic Dermatitis Across a Diverse Patient Population in a Multi-site Hospital System
2个月前
已完结
皖公网安备34019202002308
